NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
9.14
-0.49 (-5.04%)
Mar 31, 2025, 9:45 AM EDT - Market open
NeoGenomics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for NeoGenomics stock have an average target of 19.78, with a low estimate of 16 and a high estimate of 26. The average target predicts an increase of 116.53% from the current stock price of 9.14.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 26, 2025.
Analyst Ratings
The average analyst rating for NeoGenomics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +97.04% | Feb 26, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $19 → $16 | Hold | Maintains | $19 → $16 | +75.15% | Feb 19, 2025 |
| Needham | Needham | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +97.04% | Feb 19, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +97.04% | Jan 28, 2025 |
| Benchmark | Benchmark | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 16, 2025 |
Financial Forecast
Revenue This Year
745.72M
from 660.57M
Increased by 12.89%
Revenue Next Year
830.43M
from 745.72M
Increased by 11.36%
EPS This Year
0.18
from -0.62
EPS Next Year
0.35
from 0.18
Increased by 96.99%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 777.6M | 872.7M | 991.7M |
| Avg | 745.7M | 830.4M | 930.1M |
| Low | 719.1M | 793.0M | 874.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 17.7% | 17.0% | 19.4% |
| Avg | 12.9% | 11.4% | 12.0% |
| Low | 8.9% | 6.3% | 5.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.36 | 0.46 | 0.81 |
| Avg | 0.18 | 0.35 | 0.60 |
| Low | 0.10 | 0.24 | 0.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 154.4% | 128.1% |
| Avg | - | 97.0% | 69.1% |
| Low | - | 30.7% | 41.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.